Salute e Benessere

Colorectal Cancer Treatment Market Size is Projected to Reach USD 24.77 Billion…

The report runs an in-depth analysis of market trends, key players, and future opportunities. The colorectal cancer treatment market comprises a vast array of products and services that are expected to register strength during the forecast period. The report runs an in-depth analysis of market trends, key players, and future opportunities. The colorectal cancer treatment market comprises a vast array of products and services that are expected to register strength during the forecast period...
PR Newswire
08/07/2025

Fluorine-18 Market Size Projected to USD 2.54 Billion by 2031 with 4.7% CAGR…

The fluorine-18 market analysis considers various applications of an array of products and services that are expected to contribute to the market performance in the coming years. The report runs an in-depth analysis of market trends, key players, and future opportunities. The fluorine-18 market analysis considers various applications of an array of products and services that are expected to contribute to the market performance in the coming years. The report runs an in-depth analysis of…
PR Newswire
08/07/2025

Dental Bone Graft and Substitutes Market to Hit USD 1,098.48 million by 2031 |…

A dental bone graft becomes necessary when there is a loss of bone in the jaw. This treatment is often conducted before the placement of dental implants or when bone loss negatively impacts surrounding teeth. A dental bone graft increases the volume and density of the jaw in areas where bone has been lost. The graft material can be sourced from the patient's body (autogenous), purchased from a human tissue bank (allograft), or obtained from an animal tissue bank (xenograft). In certain cases…
PR Newswire
08/07/2025

$2.35 Billion by 2030: Why In Situ Hybridization Is Revolutionizing Molecular…

The global in situ hybridization market, valued at USD 1.64 billion in 2025, is projected to reach USD 2.35 billion by 2030, growing at a CAGR of 7.4%. This growth is driven by the expanding role of ISH in precision medicine, laboratory-developed tests (LDTs), and spatial transcriptomics. Technological innovations—including multiplex ISH, high-sensitivity probes, and automation—are enabling more accurate, efficient, and spatially resolved gene expression analysis in both clinical and research…
PR Newswire
08/07/2025

Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention

Market forecasts suggest oncology could be one of the decade's fastest-growing sectors. Nova One Advisor projects the global oncology drug market will reach US$366.24 billion by 2034, with a 7.4% CAGR. Other firms are even more bullish—ResearchAndMarkets sees the market hittingUS$866.1 billion, while Vision Research Reports expects revenue in 2034 to surpass US$903.81 billion, fueled by rising demand for advanced diagnostics and targeted therapies. For emerging cancer stocks, the timing couldn't…
PR Newswire
08/07/2025

Biosensors Market worth $54.37 billion by 2030 - Exclusive Report by…

Browse in-depth TOC on "Biosensors Market" Browse in-depth TOC on "Biosensors Market" 198 – Tables 57 – Figures 227 – Pages Biosensors Market Report Scope: Wearable biosensors will witness the highest CAGR during the forecast period. Wearable biosensors typically combine wearable electronics and biosensors. They are a recent advancement in healthcare technology, enabling monitoring of vital signs in patients, athletes, the elderly, children, including premature...
PR Newswire
08/07/2025

Q'Apel Medical Announces U.S. FDA Clearance for the Zebra Neurovascular Access…

Purpose-built from a single full-length hypotube, the Zebra Neurovascular Access System features a distinctive pattern of laser-cut stripes. This pattern is designed to deliver high-performance catheter construction with greater dynamic flexibility from tip to tail, providing support and flexibility where needed. The unique inner diameter (ID) to outer diameter (OD) ratio maximizes the inner lumen, without ledges, to provide optimal support during device delivery. Zebra's 7F accommodates…
PR Newswire
08/07/2025

Healthcare's $110B AI Surge Is Picking Up Speed--and It's Just the Beginning

VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- As artificial intelligence reshapes the future of medicine, understanding how patients actually feel about it is becoming just as critical as the technology itself. A new study published in Nature introduced an "AI Affinity Score" to measure patient comfort with AI in clinical settings—showing that education level and region heavily influence acceptance. The findings suggest that personalizing AI integration based on patient attitudes can…
PR Newswire
08/07/2025

Metabolon Announces a Quarter Century of Scientific Innovation, Industry…

Founded in 2000, Metabolon pioneered the field of metabolomics by unlocking the potential of small molecules to drive breakthrough discoveries across clinical research, drug development, precision medicine, and beyond. Today, Metabolon is the industry's leading metabolomics service provider with over 25 years of experience delivering high-quality data and actionable insights to researchers worldwide. Metabolon continues to push the boundaries of scientific innovation with integrated…
PR Newswire
08/07/2025

Elegoo Launches Exclusive Deals on Bestselling 3D Printers for Prime Day 2025

Saturn 4 Ultra 16K: Next-level precision and professional performance Saturn 4 Ultra16K : Next-level precision and professional performance The Saturn 4 Ultra16Kis a standout in this year's Prime Day lineup, delivering unmatched detail and precision for demanding applications. Featuring a cutting-edge16Kmono LCD, it's ideal for creators in gaming, dentistry, and design who require exceptional details. Enhanced by a smart tank heating system and AI-powered print monitoring, the...
PR Newswire
08/07/2025

GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD…

Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home $140,000 USDneeded byAugust 15to Secure Home for young Mothers MADERA, Calif. , July 8, 2025 /PRNewswire/ -- Two of the global nutraceutical industry's most respected raw material suppliers, Cypress Minerals and Cepham Inc, have joined forces to launch an urgent...
PR Newswire
08/07/2025

Caristo to Unveil New Clinical and Research Results at SCCT 2025

Data from the large-scale implementation of CaRi-Heart technology in five National Health Service (NHS) hospitals in the UK will reveal the technology's impact on tailoring patient management with inflammation-driven risk stratification. Latest clinical results from this real-world implementation will be presented and discussed on July 19 at 7:00am at the Caristo symposium(SCCT congress venue room 512 C/F), featuring: Data from the large-scale implementation of CaRi-Heart technology in five...
PR Newswire
08/07/2025

Amazon Prime Day Exclusive: Celebrity-Loved Skincare from COSRX

The Ultimate Stock Up Moment: Snail EditionWith unbeatable prices across viral staples and trending newcomers, this Prime Day is all about snail mucin — a hero ingredient in every product below. It presents a rare opportunity to replenish skincare routines, stock up on cult favorites, and prepare for the season ahead with must-have essentials. Each item is part of the brand's best-selling Snail line that Amazon users can't stop raving about. Here are a few tried-and-tested bestsellers that…
PR Newswire
08/07/2025

Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and…

- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins - Series B round in planning to support pivotal U.S. trial - New CEO appointment signals next phase of growth and expansionLAUSANNE, Switzerland, July08, 2025(GLOBE NEWSWIRE) -- Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, today announced the closing of an oversubscribed Series A...
Nasdaq GlobeNewswire
08/07/2025

Boehringer Ingelheim Harnesses GenAI to Transform Case Intake with LifeSphere®…

As part of Boehringer's broader digital transformation strategy, the organization is now leveraging NavaX-powered Advanced Intake to process individual case safety reports (ICSRs). The solution's application of GenAI and Dynamic Data Extraction technologies is delivering tangible results: within weeks of deployment, case forms are being processed with up to 90% average data extraction accuracy — reducing manual effort despite quality control steps and accelerating timelines. As part of...
PR Newswire
08/07/2025

AIRS Medical Earns Expanded MDR Certification for AI-Powered MRI Image…

MDR certification is the EU's rigorous regulatory process for ensuring the safety and performance of medical devices, including software like SwiftMR that interacts with imaging systems. This comprehensive evaluation conforms with applicable regulatory requirements. MDR certification is the EU's rigorous regulatory process for ensuring the safety and performance of medical devices, including software like SwiftMR that interacts with imaging systems. This comprehensive evaluation conforms with...
PR Newswire
08/07/2025

TINECO ANNOUNCES CAN'T-MISS DEALS ON INNOVATIVE FLOOR CARE PRODUCTS FOR AMAZON…

As a trusted leader in the floor care category with a growing user base of over 19.5 million households and availability in over 30 countries worldwide, Tineco's vision is to make life easier through smart technology. During Prime Day, consumers can access exclusive deals that not only deliver great savings but also introduce them to a new level of convenience and efficiency in maintaining their homes. As a trusted leader in the floor care category with a growing user base of over 19.5…
PR Newswire
08/07/2025

Veeda Lifesciences announces partnership with Mango Sciences to bring AI…

This partnership promotes Veeda's objectives of investing in technology modernization and digital transformation to enhance operational efficiency and quality assurance across its clinical research operations. By deploying the AI-powered Querent™ platform, Veeda will streamline processes, improve data management capabilities, and ensure higher quality standards through broader representation of non-Caucasian populations. This will enhance clinical trial efficiency through advanced data…
PR Newswire
08/07/2025

Neuraxpharm and Dizlin Pharmaceuticals Announce Global Strategic Co-Development…

This agreement marks a pivotal milestone for Neuraxpharm as it enters the drug-device space with its first-ever combination therapy, reinforcing its commitment to pioneering innovation in CNS and addressing some of the most pressing unmet needs in neurological care. This agreement marks a pivotal milestone for Neuraxpharm as it enters the drug-device space with its first-ever combination therapy, reinforcing its commitment to pioneering innovation in CNS and addressing some of the most…
PR Newswire
08/07/2025

Essity awarded supplier engagement leader by CDP for sixth consecutive year

Essity is dedicated to fostering strong partnerships to collectively reduce Scope 3 related carbon emissions, including sourced key raw materials, by 35% by 2030. For 2024, Essity reported Scope 3 emissions reduction of 21%. Essity is dedicated to fostering strong partnerships to collectively reduce Scope 3 related carbon emissions, including sourced key raw materials, by 35% by 2030. For 2024, Essity reported Scope 3 emissions reduction of 21%. "Our approach to supplier collaboration is...
PR Newswire
08/07/2025

UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in…

With a patent-pending formula and international expansion underway, BioAro positions itself as a front-runner in the multi-billion-dollar longevity and wellness sector BioAro has announced the launch of its first nutraceutical product under its new supplement line: Longevity+™, a patent-pending, scientifically formulated capsule designed to support healthy aging through synergistic multi-molecule integration. With approvals already secured in the United Arab Emirates (UAE), BioAro is now...
Nasdaq GlobeNewswire
08/07/2025

Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer

"We are very pleased to welcome Dr Philipson to the executive management team as CMO. He brings invaluable experience in the area of drug development, from first-in-human to Phase 3, and post-approval studies; with expertise across rare diseases, inflammation and oncology, which will be critical as we prepare for the next phase of our development," said CEO Renée Aguiar-Lucander. "We are very pleased to welcome Dr Philipson to the executive management team as CMO. He brings…
PR Newswire
08/07/2025

AB Science announces the successful completion of a EUR 1.925 million private…

PRESS RELEASEAB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 1.925 MILLION PRIVATE PLACEMENTParis, July 8, 2025, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces today the successful completion of a capital increase of a total gross amount of EUR 1.925 million subscribed by a limited number of investors (the “ Private Placement ”).The Private Placement is not subject to a prospectus requiring an approval from the French...
Nasdaq GlobeNewswire
08/07/2025

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with…

"By collaborating with international regulatory partners through Project Orbis, we are advancing our strategy to broaden access to innovative therapies for paediatric patients in Europe and ANZ." said Dr David Gillen, Chief Medical Officer at Norgine. "At Norgine, we're proud to take on some of the most complex disease areas, driven by our mission to deliver meaningful treatments where they're needed most." "By collaborating with international regulatory partners through…
PR Newswire
08/07/2025
Altri  Comunicati